Individual |
Age, ethnicity, education, income, labor force participation, marital status, religiosity, religious affiliation, risk perception |
|
Product characteristics |
Color, smell, size, volume, consistency |
Household |
Resources, living conditions (toilet, water) sleeping arrangements, number and type of household residents |
Delivery mechanism |
Tablet, gel, ring, film, suppository |
Partner |
Number, type, communication, decision-making power |
Efficacy (if known) |
|
Organizational |
Trial phase (phase I, II, IIB, III, IV) Clinic features (quality of staff, waiting time, access); Workplace (schedule, relationship with co-workers, organizational culture); Community group membership |
Dosing regimen |
Daily, precoital, percoital, intermittent |
Contextual/structural |
Socio-cultural norms, local practices, HIV prevalence, urban/rural location |
Use attributes |
Ease and comfort of use, physical sensation in situ, discreetness/secrecy leakiness, side effects, ancillary benefits |
Effects on the sexual encounter |
Lubrication, effect on sexual pleasure, timing of use |
Partner's attitude about product |
Awareness, support of product use, approval/disapproval |
Product associated norms |
Stigma, community norms about product formulation |